Your session is about to expire
← Back to Search
Emollient
Petroleum Jelly for Dandruff
N/A
Waitlist Available
Led By Ryan D Stevenson, BS
Research Sponsored by Ascension Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights
All Individual Drugs Already Approved
No Placebo-Only Group
Summary
This trial is testing petroleum jelly to prevent flare-ups in patients with nonscalp seborrheic dermatitis. The jelly keeps the skin moist and blocks air, which may help reduce yeast growth that worsens the condition. Petroleum jelly has long been a favorite treatment option of dermatologists for atopic dermatitis, despite complaints of 'greasiness' by patients and their parents.
Eligible Conditions
- Dandruff
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Measuring the Effectiveness of Petroleum Jelly in Treating Nonscalp Seborrheic Dermatitis
Secondary study objectives
Patient Satisfaction ofTreatment
Awards & Highlights
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Petroleum JellyExperimental Treatment1 Intervention
Every patient will be applying petroleum jelly to the affected areas per protocol.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Benzalkonium
FDA approved
Find a Location
Who is running the clinical trial?
Ascension HealthLead Sponsor
26 Previous Clinical Trials
2,847 Total Patients Enrolled
Ascension Genesys HospitalLead Sponsor
18 Previous Clinical Trials
2,060 Total Patients Enrolled
Ryan D Stevenson, BSPrincipal InvestigatorAscension Health
Share this study with friends
Copy Link
Messenger